世界のペプチド合成市場(~2026年):試薬別(樹脂、アミノ酸、染料)、機器別(ペプチド合成装置、クロマトグラフィー、凍結乾燥機)、技術別(固相、液相、ハイブリッド・組換え体)、エンドユーザー別(製薬、バイオテクノロジー、CRO)

【英語タイトル】Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026

MarketsandMarketsが出版した調査資料(BT6462)・商品コード:BT6462
・発行会社(調査会社):MarketsandMarkets
・発行日:2022年1月6日
・ページ数:228
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥569,250見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥764,750見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥937,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
マーケッツアンドマーケッツ社は世界のペプチド合成市場規模が2021年515百万ドルから2026年730百万ドルまで、年平均7.2%成長すると予測しています。本調査レポートでは、ペプチド合成の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(試薬、機器、サービス)分析、技術別(固相ペプチド合成(SPPS)、液相ペプチド合成、ハイブリッド・組換え体)分析、エンドユーザー別(製薬・バイオテクノロジー企業、CDMO・CRO、学術・研究機関)分析、地域別分析、競争状況、企業情報などを掲載しております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のペプチド合成市場規模:製品・サービス別(試薬、機器、サービス)
・世界のペプチド合成市場規模:技術別(固相ペプチド合成(SPPS)、液相ペプチド合成、ハイブリッド・組換え体)
・世界のペプチド合成市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、CDMO・CRO、学術・研究機関)
・世界のペプチド合成市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global peptide synthesis market is projected to reach USD 730 million by 2026 USD 515 million in 2021, at a CAGR of 7.2% during the forecast period.”
Growth in this market is driven by the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers.

“The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product & service, during the forecast period”
In 2020, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions). The requirement of reagents in bulk quantities, especially in the most preferred solid-phase peptide synthesis method of peptide synthesis, is another factor responsible for the large share of this segment in the peptide synthesis market. GenScript Biotech Corporation (China), Thermo Fisher Scientific (US), AAPPTec (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Biotage AB (Sweden), CEM Corporation (US), Mesa Laboratories, Inc. (Sweden), Advanced ChemTech (US), and Merck KGaA (Germany) are some of the major players operating in the peptide synthesis reagents market.

“Asia Pacific: The fastest-growing region in the peptide synthesis market”
The peptide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The high growth in this market is attributed to growing R&D funding, rising research activity, and increasing investments by pharmaceutical and biotechnology companies in enhancing equipment and technology of production. The increasing applications of peptides in therapeutics is further expected to drive the peptide synthesis market in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level – 55%, D-level – 20%, and Others – 25%
• By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

List of Companies Profiled in the Report:
• Bachem Holding AG (Switzerland)
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• GenScript Biotech Corporation (China)
• Kaneka Corporation (Japan)
• Biotage AB (Sweden)
• Syngene International Ltd. (India)
• Mesa Laboratories inc. (US)
• CEM Corporation (US)
• ProteoGenix (France)
• Bio-Synthesis Inc. (US)
• Dalton Pharma Services (Canada)
• AAPPTec (US)
• vivitide (US)
• AnyGen Co., Ltd. (South Korea)
• CSBio (US)
• Advanced Chemtech (US)
• Luxembourg Bio Technologies Ltd. (Israel)
• JPT Peptide Technologies GmbH (Germany)
• AmbioPharm Inc. (US)
• Aurigene Pharmaceutical Services Ltd. (India)
• Corden Pharma International (Germany)
• ChemPep Inc. (US)
• CPC Scientific Inc. (US)
• Purolite Pvt Ltd. (US)

Research Coverage:
This report provides a detailed picture of the peptide synthesis market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall peptide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

【レポートの目次】

1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 34
1.3 MARKET SCOPE 35
1.3.1 MARKETS COVERED 35
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 36
1.5 LIMITATIONS 36
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 1 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 38
2.1.2 PRIMARY DATA 39
FIGURE 2 BREAKDOWN OF PRIMARIES: PEPTIDE SYNTHESIS MARKET 40
2.2 MARKET ESTIMATION METHODOLOGY 40
FIGURE 3 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020 40
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020 41
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 42
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 42
2.3 MARKET GROWTH RATE PROJECTIONS 43
FIGURE 6 PEPTIDE SYNTHESIS MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 43
FIGURE 7 PEPTIDE SYNTHESIS MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 44
2.4 DATA TRIANGULATION 45
FIGURE 8 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH ASSUMPTIONS 46
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS 46
2.6 RISK ANALYSIS 47
3 EXECUTIVE SUMMARY 48
FIGURE 9 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 48
FIGURE 10 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 49
FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 49
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE PEPTIDE SYNTHESIS MARKET 50
4 PREMIUM INSIGHTS 51
4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW 51
FIGURE 13 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND INCREASING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH 51
4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE
AND COUNTRY (2020) 52
FIGURE 14 REAGENTS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE NORTH AMERICAN PEPTIDE SYNTHESIS MARKET IN 2020 52
4.3 PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2020) 52
FIGURE 15 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 52
4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 53
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE MARKET IN 2026 53
4.5 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN
THE PEPTIDE SYNTHESIS MARKET FROM 2021 TO 2026 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 55
TABLE 1 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS 56
5.2.1 DRIVERS 56
5.2.1.1 Increasing use of peptides in pharmaceutical drugs 56
TABLE 2 PEPTIDE-BASED DRUGS APPROVED BY THE FOOD AND DRUG ADMINISTRATION (FDA) (2015–2019) 57
TABLE 3 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19 58
5.2.1.2 Increase in research activities and the availability of funding for R&D 59
FIGURE 19 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 59
5.2.1.3 Development of advanced automated peptide synthesizers 60
5.2.2 RESTRAINTS 60
5.2.2.1 Lack of a unified set of regulations for therapeutic peptides 60
5.2.2.2 High cost of instruments 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Emerging markets in the Asia Pacific region 61
5.2.3.2 Development of personalized medicines 62
5.2.4 CHALLENGES 62
5.2.4.1 Issues associated with the route of administration of peptide drugs 62
5.2.4.2 Addressing the environmental impact of chemical synthesis of peptides 63
5.3 RANGES/SCENARIOS 63
FIGURE 20 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE PEPTIDE SYNTHESIS MARKET 63
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE PEPTIDE SYNTHESIS MARKET 64
FIGURE 21 PEPTIDE SYNTHESIS SCENARIO PRE AND POST COVID-19 65
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 66
5.6 VALUE CHAIN ANALYSIS 66
FIGURE 22 VALUE CHAIN ANALYSIS OF THE PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE 66
5.7 TECHNOLOGICAL ANALYSIS 67
TABLE 4 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES 67
5.8 PATENT ANALYSIS 68
FIGURE 23 PATENT APPLICATIONS FOR THE PEPTIDE SYNTHESIS MARKET, JANUARY 2011–DECEMBER 2021 68
TABLE 5 INDICATIVE LIST OF PATENTS IN THE PEPTIDE SYNTHESIS MARKET 68
5.9 ECOSYSTEM ANALYSIS OF THE PEPTIDE SYNTHESIS MARKET 70
TABLE 6 SUPPLY CHAIN ECOSYSTEM 70
5.10 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS 72
5.10.1 THREAT OF NEW ENTRANTS 72
5.10.2 THREAT OF SUBSTITUTES 72
5.10.3 BARGAINING POWER OF SUPPLIERS 72
5.10.4 BARGAINING POWER OF BUYERS 72
5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 73
5.11 REGULATORY ANALYSIS 73
6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE 75
6.1 INTRODUCTION 76
TABLE 8 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 76
6.2 REAGENTS 76
TABLE 9 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 77
TABLE 10 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 77
TABLE 11 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 77
TABLE 12 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 78
TABLE 13 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 78
TABLE 14 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 78

6.2.1 RESINS 79
6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost the market for resins 79
TABLE 15 PEPTIDE SYNTHESIS RESINS MARKET, BY REGION,
2019–2026 (USD MILLION) 79
TABLE 16 NORTH AMERICA: PEPTIDE SYNTHESIS RESINS MARKE, BY COUNTRY,
2019–2026 (USD MILLION) 79
TABLE 17 EUROPE: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
TABLE 18 ASIA PACIFIC: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
TABLE 19 LATIN AMERICA: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
6.2.2 AMINO ACIDS 81
6.2.2.1 Amino acids are the basic building blocks for peptide synthesis 81
TABLE 20 PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY REGION,
2019–2026 (USD MILLION) 81
TABLE 21 NORTH AMERICA: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
TABLE 22 EUROPE: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82
TABLE 23 ASIA PACIFIC: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 24 LATIN AMERICA: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 82
6.2.3 COUPLING REAGENTS 83
6.2.3.1 Coupling reagents play a vital role in the peptide bond formation 83
TABLE 25 PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 83
TABLE 26 NORTH AMERICA: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 83
TABLE 27 EUROPE: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 29 LATIN AMERICA: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 84
6.2.4 DYES & FLUORESCENT LABELING REAGENTS 85
6.2.4.1 Fluorescent labeling reagents are crucial to understand the success rate of peptide synthesis reactions 85
TABLE 30 PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 85
TABLE 31 NORTH AMERICA: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 85
TABLE 32 EUROPE: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
TABLE 33 ASIA PACIFIC: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
TABLE 34 LATIN AMERICA: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
6.2.5 OTHER REAGENTS 87
TABLE 35 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION,
2019–2026 (USD MILLION) 87
TABLE 36 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS,
BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 37 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 38 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS,
BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 39 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS,
BY COUNTRY, 2019–2026 (USD MILLION) 88
6.3 EQUIPMENT 89
TABLE 40 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 89
TABLE 41 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 89
TABLE 42 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 43 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
TABLE 44 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 45 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 91
6.3.1 PEPTIDE SYNTHESIZERS 91
6.3.1.1 Rising automation in peptide synthesizers to drive market growth 91
TABLE 46 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN THE MARKET 92
TABLE 47 PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2019–2026 (USD MILLION) 92
TABLE 48 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 93
TABLE 49 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 93
TABLE 50 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 93
TABLE 51 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 94
6.3.2 CHROMATOGRAPHY EQUIPMENT 94
6.3.2.1 Reverse-phase HPLC is used for the purification of synthetic peptides 94
TABLE 52 PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION) 94
TABLE 53 NORTH AMERICA: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 54 EUROPE: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 55 ASIA PACIFIC: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 56 LATIN AMERICA: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 96
6.3.3 LYOPHILIZERS 96
6.3.3.1 Lyophilization enables longer shelf life and eases the transportation of peptides 96
TABLE 57 PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY REGION,
2019–2026 (USD MILLION) 96
TABLE 58 NORTH AMERICA: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 59 EUROPE: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 60 ASIA PACIFIC: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 61 LATIN AMERICA: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
6.4 SERVICES 98
6.4.1 RISING RESEARCH ACTIVITIES IN THE PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS FIELDS TO DRIVE MARKET GROWTH 98
TABLE 62 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 98
TABLE 63 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 64 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 65 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 66 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY 101
7.1 INTRODUCTION 102
TABLE 67 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 102
7.2 SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) 102
7.2.1 EASE OF USE IS A KEY ADVANTAGE ASSOCIATED WITH SPPS TECHNOLOGY 102
TABLE 68 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION,
2019–2026 (USD MILLION) 103
TABLE 69 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 70 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
TABLE 71 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 72 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS 104
7.3.1 LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES CAN BE PRODUCED COST EFFECTIVELY WITH THE SOLUTION-PHASE PEPTIDE SYNTHESIS TECHNOLOGY 104
TABLE 73 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION,
2019–2026 (USD MILLION) 105
TABLE 74 NORTH AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 75 EUROPE: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 76 ASIA PACIFIC: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 77 LATIN AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 106
7.4 HYBRID & RECOMBINANT TECHNOLOGY 107
7.4.1 HYBRID & RECOMBINANT METHOD ENABLES THE PRODUCTION OF PEPTIDES WITH HIGHER COMPLEXITY 107
TABLE 78 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION,
2019–2026 (USD MILLION) 107
TABLE 79 NORTH AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 80 EUROPE: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 81 ASIA PACIFIC: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 82 LATIN AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 109
8 PEPTIDE SYNTHESIS MARKET, BY END USER 110
8.1 INTRODUCTION 111
TABLE 83 PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION) 111
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 111
8.2.1 PEPTIDE SYNTHESIS PRODUCTS ARE MOST WIDELY USED BY PHARMA & BIOTEC COMPANIES FOR DRUG DEVELOPMENT APPLICATIONS 111
TABLE 84 PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 112
TABLE 85 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 86 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 113
TABLE 87 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 113
TABLE 88 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 113
8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS & CROS) 114
8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES IS DRIVING THE GROWTH OF CDMOS & CROS 114
TABLE 89 PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY REGION,
2019–2026 (USD MILLION) 114
TABLE 90 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS,
BY COUNTRY, 2019–2026 (USD MILLION) 115
TABLE 91 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY COUNTRY, 2019–2026 (USD MILLION) 115
TABLE 92 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS,
BY COUNTRY, 2019–2026 (USD MILLION) 115
TABLE 93 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS,
BY COUNTRY, 2019–2026 (USD MILLION) 116
8.4 ACADEMIC & RESEARCH INSTITUTES 116
8.4.1 INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO DRIVE MARKET GROWTH 116
TABLE 94 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION) 117
TABLE 95 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 96 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 118
TABLE 97 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 118
TABLE 98 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 118
9 PEPTIDE SYNTHESIS MARKET, BY REGION 119
9.1 INTRODUCTION 120
FIGURE 24 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 120
TABLE 99 PEPTIDE SYNTHESIS MARKET, BY REGION, 2019–2026 (USD MILLION) 121
9.2 NORTH AMERICA 121
FIGURE 25 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT 122
TABLE 100 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 101 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 123
TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 103 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 104 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 124
TABLE 105 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 124
9.2.1 US 124
9.2.1.1 The US dominates the North American peptide synthesis market 124
TABLE 106 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 125
TABLE 107 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 108 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 109 US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 126
TABLE 110 US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION) 126
9.2.2 CANADA 127
9.2.2.1 Availability of research funding in Canada to drive market growth 127
TABLE 111 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 127
TABLE 112 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 113 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 114 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 128
TABLE 115 CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 129
9.3 EUROPE 129
TABLE 116 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 117 EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 130
TABLE 118 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 119 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 120 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 131
TABLE 121 EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 131
9.3.1 GERMANY 131
9.3.1.1 Strong academic base and rising awareness are key growth drivers in Germany 131
TABLE 122 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 132
TABLE 123 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 124 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 125 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 133
TABLE 126 GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 USD MILLION) 133
9.3.2 UK 134
9.3.2.1 Growth in life science research to drive market growth 134
TABLE 127 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 134
TABLE 128 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 129 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 130 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 135
TABLE 131 UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION) 135
9.3.3 FRANCE 136
9.3.3.1 Government funding for proteomics and genomics research to propel market growth 136
TABLE 132 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 136
TABLE 133 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 134 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 135 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 137
TABLE 136 FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 138
9.3.4 ITALY 138
9.3.4.1 Increasing life science research to boost the market growth in Italy 138
TABLE 137 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 139
TABLE 138 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 139 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 140 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 140
TABLE 141 ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 USD MILLION) 140
9.3.5 SPAIN 140
9.3.5.1 Rising focus on research and innovation to support market growth 140
TABLE 142 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 141
TABLE 143 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 144 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 145 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 142
TABLE 146 SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 USD MILLION) 142
9.3.6 REST OF EUROPE 142
TABLE 147 ROE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 143
TABLE 148 ROE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 149 ROE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 150 ROE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 144
TABLE 151 ROE: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 144
9.4 ASIA PACIFIC (APAC) 144
FIGURE 26 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT 145
TABLE 152 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 146
TABLE 153 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 146
TABLE 154 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 155 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 156 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 147
TABLE 157 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 147
9.4.1 CHINA 148
9.4.1.1 China to register the highest growth rate due to increasing investments in R&D 148
TABLE 158 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 148
TABLE 159 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 160 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 161 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 149
TABLE 162 CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 150
9.4.2 JAPAN 150
9.4.2.1 Rising collaborations between companies in Japan to propel market growth 150
TABLE 163 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 151
TABLE 164 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 165 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 166 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 152
TABLE 167 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 152
9.4.3 INDIA 152
9.4.3.1 Government support for scientific research to drive market growth 152
TABLE 168 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 153
TABLE 169 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 170 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 171 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 154
TABLE 172 INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 154
9.4.4 SOUTH KOREA 155
9.4.4.1 Growing research efforts in the biopharmaceutical sector to boost market growth 155
TABLE 173 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 155
TABLE 174 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 175 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 176 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 156
TABLE 177 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 157
9.4.5 REST OF ASIA PACIFIC (ROAPAC) 157
TABLE 178 ROAPAC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 158
TABLE 179 ROAPAC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 180 ROAPAC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 181 ROAPAC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 159
TABLE 182 ROAPAC: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 159
9.5 LATIN AMERICA 159
TABLE 183 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 160
TABLE 184 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 160
TABLE 185 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 186 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 187 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 161
TABLE 188 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 161
9.5.1 BRAZIL 162
9.5.1.1 Rising government investments in research to support market growth 162
TABLE 189 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 162
TABLE 190 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 191 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 192 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 163
TABLE 193 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 163
9.5.2 MEXICO 164
9.5.2.1 Mexico is the second-largest pharmaceutical market in Latin America 164
TABLE 194 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 164
TABLE 195 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 196 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 197 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 165
TABLE 198 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 165
9.5.3 REST OF LATIN AMERICA (ROLATAM) 166
TABLE 199 ROLATAM: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 166
TABLE 200 ROLATAM: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 201 ROLATAM: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 202 ROLATAM: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 167
TABLE 203 ROLATAM: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 167
9.6 MIDDLE EAST & AFRICA 168
9.6.1 GROWING PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES AND INCREASING R&D ACTIVITIES TO DRIVE MARKET GROWTH 168
TABLE 204 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 168
TABLE 205 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 206 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 207 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 169
TABLE 208 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER,
2019–2026 (USD MILLION) 170

10 COMPETITIVE LANDSCAPE 171
10.1 OVERVIEW 171
10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 172
FIGURE 27 KEY PLAYER STRATEGIES IN THE PEPTIDE SYNTHESIS MARKET, 2018-2021 172
10.3 MARKET SHARE ANALYSIS 173
FIGURE 28 PEPTIDE SYNTHESIS MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 173
TABLE 209 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION 173
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 175
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE PEPTIDE SYNTHESIS MARKET, 2018 TO 2020 175
10.5 COMPANY EVALUATION QUADRANT 176
10.5.1 STARS 176
10.5.2 EMERGING LEADERS 176
10.5.3 PERVASIVE PLAYERS 176
10.5.4 PARTICIPANTS 176
FIGURE 30 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION QUADRANT, 2020 177
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 178
10.6.1 PROGRESSIVE COMPANIES 178
10.6.2 STARTING BLOCKS 178
10.6.3 RESPONSIVE COMPANIES 178
10.6.4 DYNAMIC COMPANIES 178
FIGURE 31 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020 179
10.7 COMPANY PRODUCT FOOTPRINT 180
TABLE 210 PRODUCT/SERVICE PORTFOLIO ANALYSIS: PEPTIDE SYNTHESIS MARKET (2020) 180
10.8 COMPANY GEOGRAPHIC FOOTPRINT 181
TABLE 211 GEOGRAPHIC REVENUE MIX: PEPTIDE SYNTHESIS MARKET (2020) 181
10.9 COMPETITIVE SCENARIO 182
TABLE 212 PRODUCT & SERVICE LAUNCHES 182
TABLE 213 DEALS 183
TABLE 214 OTHER DEVELOPMENTS 184
11 COMPANY PROFILES 185
11.1 KEY PLAYERS 185
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 GENSCRIPT BIOTECH CORPORATION 185
TABLE 215 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW 185
FIGURE 32 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2020) 186
11.1.2 THERMO FISHER SCIENTIFIC 188
TABLE 216 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 188
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 189
11.1.3 MERCK KGAA 192
TABLE 217 MERCK KGAA: BUSINESS OVERVIEW 192
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2020) 193
11.1.4 BACHEM HOLDING AG 196
TABLE 218 BACHEM HOLDING AG: BUSINESS OVERVIEW 196
FIGURE 35 BACHEM HOLDING AG: COMPANY SNAPSHOT (2020) 197
11.1.5 KANEKA CORPORATION 199
TABLE 219 KANEKA CORPORATION: BUSINESS OVERVIEW 199
FIGURE 36 KANEKA CORPORATION: COMPANY SNAPSHOT (2020) 200
11.1.6 BIOTAGE AB 203
TABLE 220 BIOTAGE AB: BUSINESS OVERVIEW 203
FIGURE 37 BIOTAGE AB: COMPANY SNAPSHOT (2020) 204
11.1.7 SYNGENE INTERNATIONAL LIMITED 206
TABLE 221 SYNGENE INTERNATIONAL LIMITED: BUSINESS OVERVIEW 206
FIGURE 38 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020) 206
11.1.8 MESA LABORATORIES, INC. 208
TABLE 222 MESA LABORATORIES, INC.: BUSINESS OVERVIEW 208
FIGURE 39 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 209
11.1.9 CEM CORPORATION 211
TABLE 223 CEM CORPORATION: BUSINESS OVERVIEW 211
11.1.10 PROTEOGENIX 214
TABLE 224 PROTEOGENIX: BUSINESS OVERVIEW 214
11.1.11 BIO-SYNTHESIS INC. 215
TABLE 225 BIO-SYNTHESIS INC.: BUSINESS OVERVIEW 215
11.1.12 DALTON PHARMA SERVICES 217
TABLE 226 DALTON PHARMA SERVICES: BUSINESS OVERVIEW 217
11.1.13 AAPPTEC 219
TABLE 227 AAPPTEC: BUSINESS OVERVIEW 219
11.1.14 VIVITIDE 222
TABLE 228 VIVITIDE: BUSINESS OVERVIEW 222
11.1.15 ANYGEN CO., LTD. 224
TABLE 229 ANYGEN CO., LTD.: BUSINESS OVERVIEW 224
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 225
11.2.1 CSBIO 225
11.2.2 ADVANCED CHEMTECH 226
11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD. 226
11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH 227
11.2.5 AMBIOPHARM INC. 227
11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD. 228
11.2.7 CORDENPHARMA INTERNATIONAL 228
11.2.8 CHEMPEP INC. 229
11.2.9 CPC SCIENTIFIC INC. 230
11.2.10 PUROLITE PVT.LTD. 230
12 APPENDIX 231
12.1 DISCUSSION GUIDE 231
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 234
12.3 AVAILABLE CUSTOMIZATIONS 236
12.4 RELATED REPORTS 236
12.5 AUTHOR DETAILS 237



★調査レポート[世界のペプチド合成市場(~2026年):試薬別(樹脂、アミノ酸、染料)、機器別(ペプチド合成装置、クロマトグラフィー、凍結乾燥機)、技術別(固相、液相、ハイブリッド・組換え体)、エンドユーザー別(製薬、バイオテクノロジー、CRO)] (コード:BT6462)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のペプチド合成市場(~2026年):試薬別(樹脂、アミノ酸、染料)、機器別(ペプチド合成装置、クロマトグラフィー、凍結乾燥機)、技術別(固相、液相、ハイブリッド・組換え体)、エンドユーザー別(製薬、バイオテクノロジー、CRO)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆